Biomedical Engineering Reference
In-Depth Information
Hayashi, M., T. Sofuni, and M. Ishidate Jr. 1983. An application of acridine orange fluorescent staining to the
micronucleus test.
Mutation Research Letters
120(4):241-247.
He, F., and D. Y. Zhao. 2005. Preparation and characterization of a new class of starch-stabilized bimetallic
nanoparticles for degradation of chlorinated hydrocarbons in water.
Environmental Science & Technology
39(9):3314-3320. doi: 10.1021/Es048743y.
Hoet, P. H., I. Bruske-Hohlfeld, and O. V. Salata. 2004. Nanoparticles—Known and unknown health risks.
Journal of Nanobiotechnology
2(1):12. doi: 1477-3155-2-12 [pii] 10.1186/1477-3155-2-12.
Hrubesh, L. W., and J. F. Poco. 1995. Thin aerogel films for optical, thermal, acoustic and electronic applica-
tions.
Journal of Non-Crystalline Solids
188(1-2):46-53. doi: 10.1016/0022-3093(95)00028-3.
Ibuki, Y., and T. Toyooka. 2012. Nanoparticle uptake measured by flow cytometry. In: J. Reineke (ed.),
Nanotoxicity
, 157-166. New York: Springer.
Ishida, T., H. Harashima, and H. Kiwada. 2001. Interactions of liposomes with cells
in vitro
and
in vivo
:
Opsonins and receptors.
Current Drug Metabolism
2(4):397-409.
Jain, K. K. 2005. The role of nanobiotechnology in drug discovery.
Drug Discovery Today
10(21):1435-1442.
doi: 10.1016/S1359-6446(05)03573-7.
Jaisi, D. P., and M. Elimelech. 2009. Single-walled carbon nanotubes exhibit limited transport in soil columns.
Environmental Science & Technology
43(24):9161-9166. doi: 10.1021/es901927y.
Jallouli, Y., A. Paillard, J. Chang, E. Sevin, and D. Betbeder. 2007. Influence of surface charge and inner
composition of porous nanoparticles to cross blood-brain barrier
in vitro
.
International Journal of
Pharmaceutics
344(1-2):103-109. doi: 10.1016/j.ijpharm.2007.06.023.
Kagan, V. E., N. V. Konduru, W. Feng, B. L. Allen, J. Conroy, Y. Volkov, Vlasova II, N. A. Belikova et al. 2010.
Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation.
Nature
Nanotechnology
5(5):354-359.
Kennedy, C. B., S. D. Scott, and F. G. Ferris. 2004. Hydrothermal phase stabilization of 2-line
ferrihydrite by bacteria.
Chemical Geology
212(3-4):269-277. doi: http://dx.doi.org/10.1016/j.
chemgeo.2004.08.017.
Khan, M. K., S. S. Nigavekar, L. D. Minc, M. S. Kariapper, B. M. Nair, W. G. Lesniak, and L. P. Balogh.
2005.
In vivo
biodistribution of dendrimers and dendrimer nanocomposites—Implications for
cancer imaging and therapy.
Technology in Cancer Research and Treatment
4(6):603-613. doi:
d=3022&c=4191&p=13201&do=detail [pii].
Klaine, S. J., P. J. J. Alvarez, G. E. Batley, T. F. Fernandes, R. D. Handy, D. Y. Lyon, S. Mahendra, M. J.
McLaughlin, and J. R. Lead. 2009. Nanomaterials in the environment: Behavior, fate, bioavailability,
and effects.
Environmental Toxicology and Chemistry
27(9):1825-1851.
Kneuer, C., M. Sameti, U. Bakowsky, T. Schiestel, H. Schirra, H. Schmidt, and C. M. Lehr. 2000. A nonvi-
ral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells
in vitro
.
Bioconjugate Chemistry
11(6):926-932. doi: 10.1021/Bc0000637.
Kroll, A., M. H. Pillukat, D. Hahn, and J. Schnekenburger. 2009. Current
in vitro
methods in nanoparticle
risk assessment: Limitations and challenges.
European Journal of Pharmaceutics and Biopharmaceutics
72(2):370-377.
Kubik, T., K. Bogunia-Kubik, and M. Sugisaka. 2005. Nanotechnology on duty in medical applications.
Current Pharmaceutical Biotechnology
6(1):17-33.
Kurepa, J., T. Paunesku, S. Vogt, H. Arora, B. M. Rabatic, J. Lu, M. B. Wanzer, G. E. Woloschak, and
J. A. Smalle. 2010. Uptake and distribution of ultrasmall anatase TiO
2
Alizarin red S nanoconjugates in
Arabidopsis thaliana
.
Nano Lett
10(7):2296-2302. doi: 10.1021/nl903518f.
Lam, C. W., J. T. James, R. McCluskey, and R. L. Hunter. 2004. Pulmonary toxicity of single-wall carbon
nanotubes in mice 7 and 90 days after intratracheal instillation.
Toxicological Sciences
77(1):126-134.
doi: 10.1093/toxsci/kfg243.
Lanone, S., and J. Boczkowski. 2006. Biomedical applications and potential health risks of nanomaterials:
Molecular mechanisms.
Current Molecular Medicine
6(6):651-663. doi: 10.2174/ 156652406778195026.
Lanone, S., F. Rogerieux, J. Geys, A. Dupont, E. Maillot-Marechal, J. Boczkowski, G. Lacroix, and P. Hoet.
2009. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macro-
phage cell lines.
Particle and Fibre Toxicology
6(1):14.
LaVan, D. A., T. McGuire, and R. Langer. 2003. Small-scale systems for
in vivo
drug delivery.
Nature
Biotechnology
21(10):1184-1191. doi: 10.1038/Nbt876.
Lee, C.-W., A. Afzalian, N. D. Akhavan, R. Yan, I. Ferain, and J.-P. Colinge. 2009. Junctionless multigate field-
effect transistor.
Applied Physics Letters
94(5):053511-053511-2.
Lee, J., G. D. Lilly, R. C. Doty, P. Podsiadlo, and N. A. Kotov. 2009.
In vitro
toxicity testing of nanoparticles in
3D cell culture.
Small
5(10):1213-1221.
